The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.
- DOI
- 10.1016/j.yexcr.2026.115142
- Published
- 2026 Sep 1
- Container
- Experimental cell research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.yexcr.2026.115142,
title = {The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.},
author = {Abdelgawwad El-Sehrawy AAM and Sayed U and Farrukh A and Juraeva MM and Nargiza A and Yulduz U and Singhal D and Shefali},
year = {2026},
journal = {Experimental cell research},
doi = {10.1016/j.yexcr.2026.115142},
url = {https://doi.org/10.1016/j.yexcr.2026.115142}
}RIS
TY - JOUR TI - The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy. AU - Abdelgawwad El-Sehrawy AAM AU - Sayed U AU - Farrukh A AU - Juraeva MM AU - Nargiza A AU - Yulduz U AU - Singhal D AU - Shefali PY - 2026 JO - Experimental cell research DO - 10.1016/j.yexcr.2026.115142 UR - https://doi.org/10.1016/j.yexcr.2026.115142 ER -
APA
AAM, A. E., U, S., A, F., MM, J., A, N., U, Y., D, S., & Shefali (2026). The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy.. Experimental cell research. https://doi.org/10.1016/j.yexcr.2026.115142
Source records
- pubmed · retrieved 2026-09-26T21:47:43.350Z